Search results
Bristol plant blown up in controlled explosion
BBC News· 9 hours agoA former processing plant was blown up using 300kg of explosives in a controlled blast. The Avlon Works building in Avonmouth, near Bristol, was reduced...
What the U.K. Election Means for Oil Stocks and Other Sectors
Barrons.com· 19 hours agoFormer Prime Minister Liz Truss, who crashed the economy, lost her seat and Nigel Farage, a friend...
AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Zacks via Yahoo Finance Canada· 20 hours agoThe European Commission approves AstraZeneca's (AZN) Tagrisso in combination with chemotherapy for...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 20 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
Opinion: Sometimes conspiracy theorists get things sort of right
The Globe and Mail· 21 hours agoJen Gerson is a contributing columnist for The Globe and Mail. Spend too much time arguing on the...
Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe
Zacks via Yahoo Finance Canada· 21 hours agoApellis' (APLS) revenues rise on the back of the robust uptake of Syfovre for the GA indication....
Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Simply Wall St. via Yahoo Finance Canada· 21 hours agoGenerally speaking the aim of active stock picking is to find companies that provide returns that...
Drug companies challenge Minnesota prescription discount law in federal court
MPR News· 3 days agoSeveral drug companies filed lawsuits in federal court this week challenging a Minnesota law...
V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76
New York Times· 3 days agoV. Craig Jordan, a pharmacologist whose discovery that a failed contraceptive, tamoxifen, could...
AstraZeneca Wins Dismissal Of Shareholder Suit Over Viela Sale
Bloomberg Law· 3 days agoAstraZeneca didn’t owe a fiduciary duty to Viela stockholders because it lacked control, and it didn’t materially mislead or omit facts in communications with shareholders ...